Johnson and Johnson

FDA Adds Label Warning to J&J’s and Legend Biotech’s Cancer Therapy

October 12, 2025 · Business

The U.S. Food and Drug Administration approved on Friday labeling changes for the blood cancer therapy of Johnson & Johnson and its partner Legend Biotech to include a…

J&J’s Kenvue Deal Could Be Too Popular. What Happens if It Is.

August 15, 2023 · Business

Johnson and Johnson $40 billion exchange offer for shares in Kenvue is likely to generate strong interest from the healthcare company’s shareholders, resulting in participants being able to…